Managing the Elderly AML Patient: Clinical Issues and Strategies for Nurses
Last Modified: February 26, 2015
Support for this activity has been made possible through an educational grant from Boehringer Ingelheim.
Release date: February 25, 2014
Expiration date: February 25, 2015 (No Longer Valid for Credit. Viewing Only.)
Estimated time to complete: 1.25 hours
Activity URL: http://mediasite.med.upenn.edu/Mediasite/Play/5c536de92c5748ab99275da722e03bf21d
The incidence of acute myeloid leukemia (AML) is expected to increase as a result of several factors, including the aging of the population, a rise in secondary cases from environmental exposures, and wider recognition that low blood counts may be indicative of a bone marrow disorder rather than a normal consequence of aging. Lower survival rates in older patients with AML may be due to age, disease-related changes, aggressive chemotherapy, or treatment-associated adverse reactions.
The demographic shift occurring in the US during the next two decades underscores a critical need for continuing education for oncology nurses who will have an expanding role in the multidisciplinary management of older cancer patients. The complexity of caring for older adults with AML may place pressures upon the knowledge, competence, and performance of oncology practices. Oncology nurses and nurse practitioners must be able to think critically, analyze, reflect, problem-solve, and apply high-level knowledge that is evidence- and research-based to clinical interactions with patients who need their care.
Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
Adult Hematology-Oncology Nurse Practitioner
Fox Chase Cancer Center
This activity has been designed to meet the educational needs of oncology nurses and nurse practitioners involved in the care of patients with AML.
As a result of participating in the activity, learners should be better able to:
- Identify variables that influence AML prognosis and AML treatment in elderly patients
- Evaluate cognitive and physical functioning in elderly patients with AML
- Describe common treatment-related side effects and strategies for side effect management, including those associated with novel and emerging treatment options for AML
- Identify information and support resources for patients with AML and their caregivers
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:
Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC: Promotional Speakers Bureau for Millennium, Seattle Genetics, and Teva
Independent Clinical Peer Reviewer
Brandi K. Swisher, MSN, CRNP, ACONP
Oncology Nurse Practitioner
Hospital of the University of Pennsylvania
Ms. Swisher: Promotional Speakers Bureau for Celgene
John JD Juchniewicz, MCIS, CCMEP, and Natalie Kirkwood, RN, BSN, JD, Lead Nurse Planner, American Academy of CME: No relevant financial relationships with any commercial interests.
Paul J. Miniter, MS, Elizabeth Paczolt, MD, Mindy Aratow, Pat McCollum, Excellence in Medical Education: No relevant financial relationships with any commercial interests.
This activity will not review off-label or investigational information.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, Excellence in Medical Education, or American Nurses Credentialing Council's Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Participants will need to have Microsoft Silverlight to view the program. A free download is available at http://www.microsoft.com/silverlight/
For any questions, please contact: CEServices@academycme.org
© 2014. This CNE-certified activity is held as copyrighted © by American Academy of CME and Excellence in Medical Education. Through this notice, the Academy and Excellence in Medical Education grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
September 30, 2014
May 26, 2016